China SXT Pharmaceuticals, Inc. Long-Term Debt, Maturity, Year Three
China SXT Pharmaceuticals, Inc. (SXTC) had Long-Term Debt, Maturity, Year Three of CNY 54.00 thousand as of 2024-09-30, per its 6-K filed 2025-03-28.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree · last filed 2025-03-28
- 2024-09-30: Long-Term Debt, Maturity, Year Three 54.00K CNY.
- 2024-03-31: Long-Term Debt, Maturity, Year Three 54.00K CNY.
- 2023-09-30: Long-Term Debt, Maturity, Year Three 654.00K CNY.
- 2023-03-31: Long-Term Debt, Maturity, Year Three 654.00K CNY.
CNY
| Period end | Long-Term Debt, Maturity, Year Three |
|---|---|
| 2024-09-30 | 54.00K CNY 6-K · filed 2025-03-28 |
| 2024-03-31 | 54.00K CNY 20-F · filed 2024-08-13 |
| 2023-09-30 | 654.00K CNY 6-K · filed 2024-04-05 |
| 2023-03-31 | 654.00K CNY 6-K · filed 2024-04-05 |
USD
| Period end | Long-Term Debt, Maturity, Year Three |
|---|---|
| 2024-09-30 | $7.70K 6-K · filed 2025-03-28 |
| 2024-03-31 | $7.48K 20-F · filed 2024-08-13 |
| 2023-09-30 | $89.64K 6-K · filed 2024-04-05 |
| 2023-03-31 | $95.23K 6-K · filed 2024-04-05 |